home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

webinar on Design Control and the ICH Q 10 Pharmaceutical Lifecycle by global compliance trainings

 
  February 27, 2014  
     
 
Global Compliance Trainings, 201,N Squirrel road, Suite 1007, Auburn Hills, Michigan United States - 48326.
27-03-2014


Webinar Description :


Design Control, often referred to as product quality planning, has been practiced for many decades. In fact, if you have ever taken part in the review and approval of a technical document, realize that product development occurs through several stages of development with increasing complexity, andhave been involved in the evaluation, testing, and analysis of these lifecycle stages, then you have been involved in and practiced Design Control. Design Control, in simple terms, is a systematic defined sequence of events that occur in the product development and commercialization to ensure that the product meets user requirements.

The ICH Q10 Model defines the pharmaceutical lifecycle as consisting of four phases-product development, technology transfer, commercialization, and product discontinuation.

Within each of these phases, there are defined cyclical and none-cyclical sequential events that must be directed and controlled in order to assure the successful design of products that meet or surpass user requirements.

This webinar is intended to describe and explain these lifecycle phases, including the associated sub-routines. Using graphics, the inputs and outputs of each phase may be seen and studied thus providing a perspective of the relationship of the individual events to the pharmaceutical product lifecycle in its entirety.

Objectives of the Presentation:

To define and explain the inputs and outputs of the design control process that that is inherent throughout the entire product lifecycle.

To demonstrate that design control practices go far beyond compliance dictates adding value to the organization’s employees, products, and processes.

Areas Covered:

Introduction, Overview & Objectives

Defining Quality Systems & Product Quality

Defining Design Control AKA Product Quality Planning

Compliance Requirements for Design Control

Design Space

Risk and Risk Management

The ICH Q10 Pharmaceutical Product Lifecycle

Seeking Product Approval

Phases of the Cycle & Their Gateways

Sub Cyclical and Non-Cyclical Events & Their Gateways

The Role of Regulatory Submissions

The Role of the Quality and Technical Manuals

Roles and Responsibilities of Departmental Functions in Design Control

          Active Roles

          Supporting Roles

Outsourcing Impacts

Adding Design Control to Your Existing Quality System

Developing and Implementing Design Control in a new Quality System

Who will benefit:

Because all functions have at least some role in the pharmaceutical product lifecycle, the webinar will raise the awareness of the important input factors that influence their functional area.

Particularly beneficial to R&D, Engineering, Production, QA/QC, Maintenance, and IT.

Provide insight to those functions that frequently are involved in supporting product development and improvement such as Purchasing, Accounting, Sales and Marketing and Project Management.

Why you should attend:

By learning and understanding the role of product design throughout the product lifecycle, your company will realize the positive impact that product design has on achieving and maintaining product safety and effectiveness.

By learning and understanding how product design provides a systematic approach that can go beyond compliance requirements resulting in greater customer requirements as well as a more cost-effective product.

Instructor Profile
Howard Cooper has over 40 years of experience facing the challenges of managing, designing, developing, implementing, and mitigating GMP quality systems in the pharmaceutical, medical device, & food industries. He started his quality career at Anheuser-Busch as a quality management trainee which exposed him to an advanced and preventative approach toward quality. He then took this experience to the medical device industry when the medical device amendments of 1976 were being written and promulgated. He quickly distinguished himself as a change agent and a forward thinking quality leader. Mr. Cooper built on this experience to set up a pharmaceutical /medical device and combination product quality system. Since that time, he has worked with incubators, small companies, and large international corporations in the quality and regulatory affairs. In 2004, he became an independent consultant continuing his work to manage, develop, and implement quality. Mr. Cooper particularly enjoys sharing his experience with others to further develop them for successfully running quality operations.
 

Live Session for one participant

Price: $225.00

 

Bottom of Form

Top of Form

Corporate Live Session 4 to 10 participants in single location.

Price:$885.00

 

Bottom of Form

Top of Form

Recorded Session Access recorded sessions only for one participant unlimited viewing for 6 months.

Price: $275.00


 
 
Organized by: Global Compliance Trainings
Invited Speakers: Howard T Cooper
 
Deadline for Abstracts: 27th February 2014
 
Registration: 27th February 2014
E-mail: webinar@globalcompliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.